Jannik Sinner, the world number one in tennis, faced scrutiny after testing positive for the banned substance clostebol twice in March but was cleared of fault by an independent tribunal, which found he was contaminated by his physiotherapist's treatment. This ruling has sparked controversy among players, including Novak Djokovic, who criticized the perceived inconsistency in anti-doping protocols and called for standardized approaches to such cases. Djokovic emphasized that many players share concerns about unequal treatment, suggesting that financial resources might influence outcomes in doping cases. Meanwhile, Carlos Alcaraz described the situation as delicate and hinted at complexities unknown to the public. Sinner defended himself, insisting he received no special treatment and that he was provisionally suspended during the investigation. The debate continues as the tennis community awaits potential reforms in doping regulations.